DK1499623T3 - Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on - Google Patents
Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-onInfo
- Publication number
- DK1499623T3 DK1499623T3 DK03719968T DK03719968T DK1499623T3 DK 1499623 T3 DK1499623 T3 DK 1499623T3 DK 03719968 T DK03719968 T DK 03719968T DK 03719968 T DK03719968 T DK 03719968T DK 1499623 T3 DK1499623 T3 DK 1499623T3
- Authority
- DK
- Denmark
- Prior art keywords
- methyl
- carbazol
- imidazol
- tetrahydro
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D521/00—Heterocyclic compounds containing unspecified hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37632302P | 2002-04-29 | 2002-04-29 | |
PCT/US2003/013221 WO2003093281A1 (en) | 2002-04-29 | 2003-04-29 | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1499623T3 true DK1499623T3 (da) | 2007-10-08 |
Family
ID=29401332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03719968T DK1499623T3 (da) | 2002-04-29 | 2003-04-29 | Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on |
Country Status (19)
Country | Link |
---|---|
US (2) | US7098345B2 (ko) |
EP (1) | EP1499623B1 (ko) |
JP (1) | JP2005529142A (ko) |
KR (1) | KR20040104654A (ko) |
CN (1) | CN1665823A (ko) |
AT (1) | ATE364611T1 (ko) |
AU (1) | AU2003223764A1 (ko) |
CA (1) | CA2483566A1 (ko) |
DE (1) | DE60314400T2 (ko) |
DK (1) | DK1499623T3 (ko) |
ES (1) | ES2288606T3 (ko) |
HR (1) | HRP20041070A2 (ko) |
IL (1) | IL164904A0 (ko) |
MX (1) | MXPA04010846A (ko) |
NO (1) | NO20045192L (ko) |
PL (1) | PL373191A1 (ko) |
PT (1) | PT1499623E (ko) |
WO (1) | WO2003093281A1 (ko) |
ZA (1) | ZA200408934B (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL366150A1 (en) * | 2000-10-30 | 2005-01-24 | Teva Pharmaceutical Industries Ltd. | Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
US20050131045A1 (en) * | 2002-04-30 | 2005-06-16 | Judith Aronhime | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them |
KR20040104677A (ko) * | 2002-04-30 | 2004-12-10 | 비오갈 기오기스제르갸르 알티. | 신규의 온단세트론 결정 형태, 그 제조 방법, 그 신규의결정 형태를 함유하는 약학 조성물 및 이들을 이용한구역질 치료 방법 |
US7696356B2 (en) * | 2004-08-17 | 2010-04-13 | Taro Pharmaceutical Industries Limited | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom |
US7547791B2 (en) * | 2004-10-26 | 2009-06-16 | Ipca Laboratories Ltd. | One-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1H-imidazole-1-yl)methyl]-4H-carbazol-4-O |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
FI84349C (fi) | 1984-01-25 | 1991-11-25 | Glaxo Group Ltd | Foerfarande foer framstaellning av en farmakologiskt vaerdefull foerening. |
DE3688296T2 (de) | 1985-03-14 | 1993-11-04 | Beecham Group Plc | Arzneimittel zur behandlung von erbrechen. |
GB8518745D0 (en) | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
GB8518741D0 (en) | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Process |
GB8518742D0 (en) | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Process |
US4859662A (en) | 1986-11-28 | 1989-08-22 | Glaxo Group Limited | Tetrahydro-imidazolylmethylcarbazolones and analogs thereof for treating 5-HT function disturbances |
GB8630071D0 (en) | 1986-12-17 | 1987-01-28 | Glaxo Group Ltd | Medicaments |
GB8816187D0 (en) * | 1988-07-07 | 1988-08-10 | Glaxo Group Ltd | Medicaments |
GB8914804D0 (en) | 1989-06-28 | 1989-08-16 | Glaxo Group Ltd | Process |
US5344658A (en) | 1989-06-28 | 1994-09-06 | Glaxo Group Limited | Process and composition using ondansetron |
EP0591434A4 (en) | 1991-06-26 | 1994-09-14 | Sepracor Inc | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
CA2106642C (en) | 1992-10-14 | 2005-08-16 | Peter Bod | Carbazolone derivatives and process for preparing the same |
GB9423511D0 (en) | 1994-11-22 | 1995-01-11 | Glaxo Wellcome Inc | Compositions |
GB9423588D0 (en) | 1994-11-22 | 1995-01-11 | Glaxo Wellcome Inc | Compositions |
CN1045437C (zh) | 1994-12-29 | 1999-10-06 | 中国科学院上海有机化学研究所 | 恩丹西酮及其生理盐的合成 |
PL366150A1 (en) | 2000-10-30 | 2005-01-24 | Teva Pharmaceutical Industries Ltd. | Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
EP1207160A1 (en) | 2000-11-20 | 2002-05-22 | Hanmi Pharm. Co., Ltd. | Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one |
JP2004526692A (ja) | 2001-01-11 | 2004-09-02 | テバ ファーマシューティカル インダストリーズ リミティド | 純粋な塩酸オンダンセトロン二水和物を製造するための改良された方法 |
AU2002251329A1 (en) | 2002-04-25 | 2003-11-10 | Generics (Uk) Limited | Novel crystalline forms of celecoxib and other compounds |
KR20040104677A (ko) | 2002-04-30 | 2004-12-10 | 비오갈 기오기스제르갸르 알티. | 신규의 온단세트론 결정 형태, 그 제조 방법, 그 신규의결정 형태를 함유하는 약학 조성물 및 이들을 이용한구역질 치료 방법 |
-
2003
- 2003-04-29 PL PL03373191A patent/PL373191A1/xx not_active Application Discontinuation
- 2003-04-29 JP JP2004501420A patent/JP2005529142A/ja active Pending
- 2003-04-29 CA CA002483566A patent/CA2483566A1/en not_active Abandoned
- 2003-04-29 AU AU2003223764A patent/AU2003223764A1/en not_active Abandoned
- 2003-04-29 AT AT03719968T patent/ATE364611T1/de not_active IP Right Cessation
- 2003-04-29 EP EP03719968A patent/EP1499623B1/en not_active Expired - Lifetime
- 2003-04-29 US US10/425,450 patent/US7098345B2/en not_active Expired - Fee Related
- 2003-04-29 DK DK03719968T patent/DK1499623T3/da active
- 2003-04-29 KR KR10-2004-7017346A patent/KR20040104654A/ko not_active Application Discontinuation
- 2003-04-29 DE DE60314400T patent/DE60314400T2/de not_active Expired - Fee Related
- 2003-04-29 ES ES03719968T patent/ES2288606T3/es not_active Expired - Lifetime
- 2003-04-29 WO PCT/US2003/013221 patent/WO2003093281A1/en active IP Right Grant
- 2003-04-29 CN CN038154684A patent/CN1665823A/zh active Pending
- 2003-04-29 MX MXPA04010846A patent/MXPA04010846A/es unknown
- 2003-04-29 PT PT03719968T patent/PT1499623E/pt unknown
-
2004
- 2004-10-28 IL IL16490404A patent/IL164904A0/xx unknown
- 2004-11-04 ZA ZA200408934A patent/ZA200408934B/xx unknown
- 2004-11-16 HR HR20041070A patent/HRP20041070A2/hr not_active Application Discontinuation
- 2004-11-26 NO NO20045192A patent/NO20045192L/no not_active Application Discontinuation
-
2006
- 2006-07-07 US US11/482,486 patent/US20060252942A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ZA200408934B (en) | 2006-07-26 |
US7098345B2 (en) | 2006-08-29 |
PT1499623E (pt) | 2007-08-10 |
CN1665823A (zh) | 2005-09-07 |
MXPA04010846A (es) | 2005-01-25 |
US20060252942A1 (en) | 2006-11-09 |
IL164904A0 (en) | 2005-12-18 |
DE60314400D1 (de) | 2007-07-26 |
PL373191A1 (en) | 2005-08-22 |
EP1499623B1 (en) | 2007-06-13 |
US20050020655A1 (en) | 2005-01-27 |
AU2003223764A1 (en) | 2003-11-17 |
JP2005529142A (ja) | 2005-09-29 |
EP1499623A1 (en) | 2005-01-26 |
HRP20041070A2 (en) | 2005-02-28 |
CA2483566A1 (en) | 2003-11-13 |
WO2003093281A1 (en) | 2003-11-13 |
KR20040104654A (ko) | 2004-12-10 |
ES2288606T3 (es) | 2008-01-16 |
NO20045192L (no) | 2005-01-28 |
ATE364611T1 (de) | 2007-07-15 |
DE60314400T2 (de) | 2008-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200626580A (en) | Synthesis of (5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester | |
NO20063132L (no) | Naftyridinderivater og deres anvendelse som modulatorer av muskarinreceptorer | |
NO20071629L (no) | Fremgangsmate for fremstilling av 2,7-oktadienylderivater | |
AU2003202585A1 (en) | Disubstituted thiazolyl carboxanilides and their use as microbicides | |
NO20060417L (no) | Fremgangsmate til fremstilling av 1-okten fra krakk-C4 | |
MXPA05013652A (es) | Modulador del receptor canabinoide. | |
MX2022005229A (es) | Un nuevo proceso eficaz para la sintesis de 2-amino-5-cloro-n,3-di metilbenzamida. | |
DK1499623T3 (da) | Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on | |
WO2002092564A3 (en) | Synthesis of cyclopentadiene derivatives | |
WO2004026267A3 (en) | Tri(alkylcarboxylato) gallium (iii) products and pharmaceutical compositions containing them | |
WO2021076835A8 (en) | Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid | |
WO2008021491A3 (en) | Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones | |
WO2004111047A3 (en) | Cycloalkanepyrrolopyridines as dp receptor antagonists | |
MX2022006142A (es) | Proceso para la sintesis de (3-cloro-2-piridil)hidrazina. | |
DK0595111T4 (da) | Carbazolonderivater og fremgangsmåde til deres fremstilling | |
IL185329A0 (en) | Conversion of 2-pyrazolines to pyrazoles using bromine | |
DK1102765T3 (da) | Fremgangsmåde til syntese af (1H)-benzo[c]quinolizin-3-on-derivater | |
TW200626555A (en) | A process for the preparation of 1, 3, 5-trisubstituted pyrazoles via [3+2] cycloaddition | |
MX2009009232A (es) | Nuevo procedimiento de preparacion de 3-metil-4-fenilsoxazolo [3,4-d]piridazin-7(6h)-ona. | |
DK1389188T3 (da) | Fremgangsmåde til fremstilling af biperiden II | |
RS20110079A (en) | MICROBIOLOGICAL PROCEDURE FOR THE PREPARATION OF 7ALFA-SUBSTITUTED 11ALFA-HYDROXYSTEROIDS | |
Shaban et al. | MICROWAVE-IRRADIATED SYNTHESIS OF 1, 2-DIHYDROPYRIDINES FROM N-FUNCTIONALIZED ENAMINONES AND ENALS THROUGH DOMINO CONDENSATION AND 6II-AZAELECTROCYCLIZATION | |
UA86082C2 (ru) | Производные 4-арилморфолин-3-она, способ их получения и их применение в терапии | |
WO2019191363A3 (en) | Expedient synthesis of oseltamivir and related compounds via direct olefin diazidation-diamidation reaction | |
MX2021007505A (es) | Síntesis de 3-metil-1,2,4-tiadiazol-5-carbohidrazida o de su forma deuterada con metil-d3. |